Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
Abstract
BACKGROUND: Clinical trials established the efficacy and safety of natalizumab. Data are needed over longer periods of time and in the clinical practice setting..... Read More -http://www.ms-uk.org/tysabri
Efficacy and safety of natalizumab in multiple sclerosis
Efficacy and safety of natalizumab in multiple sclerosis
MS-UK - http://www.ms-uk.org/
- HarryZ
- Family Elder
- Posts: 2572
- Joined: Tue May 25, 2004 2:00 pm
- Location: London, ON, Canada
- Contact:
Re: Efficacy and safety of natalizumab in multiple sclerosis
The stats reported don't seem to include the approx 39% of the participants from the initial numbers. Is this just poor reporting of the study or what happened to these patients?MSUK wrote:Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
Abstract
BACKGROUND: Clinical trials established the efficacy and safety of natalizumab. Data are needed over longer periods of time and in the clinical practice setting..... Read More -http://www.ms-uk.org/tysabri
-
- Family Member
- Posts: 87
- Joined: Wed Aug 14, 2013 6:43 pm
Re: Efficacy and safety of natalizumab in multiple sclerosis
Perhaps they hadn't yet reached the minimum two-year threshold reported on.
- HarryZ
- Family Elder
- Posts: 2572
- Joined: Tue May 25, 2004 2:00 pm
- Location: London, ON, Canada
- Contact:
Re: Efficacy and safety of natalizumab in multiple sclerosis
Then they should not have been a part of the study's reporting numbers on efficacy. Something just doesn't seem right here.grandsons4 wrote:Perhaps they hadn't yet reached the minimum two-year threshold reported on.
- CureOrBust
- Family Elder
- Posts: 3374
- Joined: Wed Jul 27, 2005 2:00 pm
- Location: Sydney, Australia
Re: Efficacy and safety of natalizumab in multiple sclerosis
I think the missing numbers may be partially made up of those that came up as JCV positive, and hence advised to stop taking it, but not "technically" being diagnosed or suffer specific JCV symptoms.
- HarryZ
- Family Elder
- Posts: 2572
- Joined: Tue May 25, 2004 2:00 pm
- Location: London, ON, Canada
- Contact:
Re: Efficacy and safety of natalizumab in multiple sclerosis
Hi Cure,CureOrBust wrote:I think the missing numbers may be partially made up of those that came up as JCV positive, and hence advised to stop taking it, but not "technically" being diagnosed or suffer specific JCV symptoms.
Do you think that if this was the case, those numbers should have been shown as affecting the efficacy numbers in a negative way? I think what happens in some of these studies is those patients who drop out for whatever reason are simply ignored in the overall stats.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1827 Views
-
Last post by frodo
-
- 0 Replies
- 1615 Views
-
Last post by frodo
-
- 0 Replies
- 1554 Views
-
Last post by frodo
-
- 0 Replies
- 1760 Views
-
Last post by frodo
-
- 0 Replies
- 1866 Views
-
Last post by NHE
-
- 0 Replies
- 3614 Views
-
Last post by frodo
-
- 0 Replies
- 2207 Views
-
Last post by frodo
-
- 0 Replies
- 1240 Views
-
Last post by frodo
-
- 0 Replies
- 834 Views
-
Last post by maggieMSOC